we are

Created in 2012, Neauvia is distributed in more than 80 countries worldwide. Today, it stands as a high-growth multinational corporation with production sites and subsidiaries in Italy, Switzerland, France, Spain, Poland, Germany, the UK and the US. Neauvia offers clinically proven combined solutions for healthcare practitioners and patients.

Part of the MatexLab Group, which is backed by leading central European private equity firm Abris Capital, Neauvia is a pioneer in medical aesthetics and has developed ground-breaking synergistic smart combination therapies.

our mission

Neauvia provides healthcare practitioners and patients clinically proven combined solutions with a comprehensive range of high-end technologies working in synergy. We deliver safe and more effective results for facial, body and intimate rejuvenation.

Rethinking medical aesthetics as premium experiences, by fully integrating this approach into a modern and healthy lifestyle, Neauvia empowers all beauty lovers.

our vision

Neauvia aims to inspire and shape the world of aesthetic medicine with a disruptive energy, opening up new lifestyles and creating a community that embraces our new concept of aesthetics.

Rethinking Medical Aesthetics
Rethinking Medical Aesthetics
Rethinking Medical Aesthetics

SCT smart combinaton therapy

Age-related anatomical changes are most effectively managed through the combination of science and technology. To achieve this goal, Neauvia research designed SMART COMBINATION THERAPY that combines different restorative therapies. This has been possible thanks to the in-house portfolio of products FILLERS, ENERGY BASED DEVICES AND COSMECEUTICALS developed to work synergistically with each other and organically with the body.